Pages that link to "Q33336412"

The following pages link to Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence (Q33336412):

Displaying 38 items.

• Contribution of coagulases towards Staphylococcus aureus disease and protective immunity (Q27313924) (← links)
• A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure (Q28714292) (← links)
• Binding and activation of host plasminogen on the surface of Francisella tularensis (Q33540350) (← links)
• Predicting the virulence of MRSA from its genome sequence (Q33564544) (← links)
• Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions (Q33605347) (← links)
• Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA (Q33619097) (← links)
• Evaluation of clumping factor A binding region A in a subunit vaccine against Staphylococcus aureus-induced mastitis in mice. (Q34289853) (← links)
• Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection (Q34712265) (← links)
• The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus (Q35191984) (← links)
• Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial (Q35887417) (← links)
• Coagulase and Efb of Staphylococcus aureus Have a Common Fibrinogen Binding Motif (Q36496553) (← links)
• Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection. (Q36548288) (← links)
• Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection (Q36736262) (← links)
• Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice (Q36974423) (← links)
• Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease (Q37078631) (← links)
• Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis. (Q37548140) (← links)
• Lessons from the Crystal Structure of the S. aureus Surface Protein Clumping Factor A in Complex With Tefibazumab, an Inhibiting Monoclonal Antibody (Q37605209) (← links)
• Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. (Q37648719) (← links)
• Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins (Q37778852) (← links)
• Strategies for and advances in the development ofStaphylococcus aureusprophylactic vaccines (Q37878489) (← links)
• Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors (Q38038043) (← links)
• Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus (Q38171226) (← links)
• Mouse models for infectious diseases caused by Staphylococcus aureus. (Q38207403) (← links)
• Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection (Q38801276) (← links)
• Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions. (Q38938178) (← links)
• Vaccine development to prevent Staphylococcus aureus surgical-site infections (Q39102571) (← links)
• Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis (Q39896801) (← links)
• Adaptive Upregulation of Clumping Factor A (ClfA) by Staphylococcus aureus in the Obese, Type 2 Diabetic Host Mediates Increased Virulence (Q40287232) (← links)
• Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention (Q40697398) (← links)
• Protein adsorption, platelet adhesion, and bacterial adhesion to polyethylene-glycol-textured polyurethane biomaterial surfaces (Q40870552) (← links)
• Cell Wall-Anchored Surface Proteins of Staphylococcus aureus: Many Proteins, Multiple Functions (Q40871551) (← links)
• Shortening of the Lactobacillus paracasei subsp. paracasei BGNJ1-64 AggLb Protein Switches Its Activity from Auto-aggregation to Biofilm Formation. (Q41037739) (← links)
• Impacts of enterotoxin gene cluster-encoded superantigens on local and systemic experimental Staphylococcus aureus infections (Q41087462) (← links)
• Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate. (Q41117685) (← links)
• Immunogenicity analysis of Staphylococcus aureus clumping factor A genetic variants (Q42116005) (← links)
• Sortases, Surface Proteins, and Their Roles in Disease and Vaccine Development (Q64271888) (← links)
• Immunogenicity and protective efficacy of recombinant alkaline shock protein 23 from Staphylococcus aureus in a murine model (Q91871908) (← links)
• Staphylococcus aureus adhesion in endovascular infections is controlled by the ArlRS-MgrA signaling cascade (Q92216522) (← links)